Osiris Therapeutics, Inc. (NASDAQ: OSIR) 19.9% HIGHER; announced today that it has received transitional pass-through status from the Center for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE